Ozempic Weight Loss Timeline: What to Expect Month by Month
Informational only — not medical advice. Key claims are drawn from peer-reviewed research cited at the end of this article. Always consult your healthcare provider.
Quick Answer
Ozempic (semaglutide) starts at a low dose and steps up over the first months, so the early weeks are mostly about getting used to the medication. In the trial of its two highest doses (SUSTAIN FORTE), adults with type 2 diabetes not controlled on metformin, with an average BMI of about 35, lost an average of 5.6 kg (about 12 lb) on 1 mg and 6.4 kg (about 14 lb) on 2 mg over 40 weeks[2]. The trial results cited here are averages at the end of the trial (week 40 or 68), not per-month figures, and individual results vary widely.
One thing to know first: weight loss is not among Ozempic's approved uses[1]. It is approved for adults with type 2 diabetes, to improve blood sugar control and to lower the risk of certain heart and kidney problems. Many weight-loss figures you see online come from trials of semaglutide at a higher dose, and they are not the same as Ozempic's results (more on that below).
This timeline covers the weekly Ozempic injection. Ozempic also comes as a once-daily tablet with different dose steps (1.5 mg for 30 days, then 4 mg, then 9 mg if needed)[6].
Month 1: The Starting Dose (0.25 mg)
Everyone starts at 0.25 mg once a week for 4 weeks. The label uses this step to ease your body in and lower the risk of stomach side effects such as nausea[1]. The sources cited here do not report first-month weight change, so there is no figure to expect. Some people notice their appetite drop early; others do not.
Month 2: Moving to 0.5 mg
After 4 weeks, the dose goes up to 0.5 mg once a week. This can be a maintenance dose: the label lists 0.5 mg, 1 mg and 2 mg as maintenance doses, chosen based on blood sugar control[1].
Month 3 and Later: 1 mg, Then Possibly 2 mg
If your blood sugar needs more control, your prescriber can raise the dose to 1 mg after at least 4 weeks on 0.5 mg, and to 2 mg after at least 4 weeks on 1 mg. 2 mg is the maximum. The label bases this decision on blood sugar control, not weight. For adults with type 2 diabetes and chronic kidney disease, the label's recommended maintenance dose is 1 mg[1].
In SUSTAIN FORTE, people on 2 mg lost 6.4 kg on average versus 5.6 kg on 1 mg. That 0.8 kg difference was small. Counting everyone, including people who stopped treatment, it was not statistically clear; among people who stayed on treatment, 2 mg led to about 0.9 kg more loss[2].
Ozempic vs Wegovy Results
Many articles quote 15% weight loss for "Ozempic". That figure comes from STEP 1, a trial of semaglutide at 2.4 mg in adults with overweight or obesity who did not have diabetes. They lost an average of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo[3]. That 2.4 mg dose is the usual maintenance dose of Wegovy, the semaglutide injection approved for weight management[5].
Two differences help explain the gap. The dose is higher than the Ozempic injection's 2 mg maximum, and the trial in people with type 2 diabetes (STEP 2, same 2.4 mg dose) found a smaller average loss: 9.6% over 68 weeks versus 3.4% on placebo[4]. The trials also differ in length and design, so their numbers cannot be compared directly.
What Shapes Your Timeline
- Your dose: how far up the steps you go, which your prescriber decides mainly from blood sugar control and your other health conditions.
- Diabetes: the 2.4 mg trial in people with type 2 diabetes (STEP 2) found a smaller average loss than the trial in people without diabetes (STEP 1), though the two trials differed in design[3][4].
- Staying on schedule: the Ozempic injection is a once-weekly dose. The label says a missed dose can be taken within 5 days; if more than 5 days have passed, skip it and take the next dose on your usual day[1].
- Diet and activity: Ozempic is approved for use alongside diet and exercise[1].
Tracking Your Progress
- Log each weekly injection, with the dose and the injection site. A tracker like JellyPal keeps that history in one place.
- Weigh yourself at the same time of day, on the same day each week, and look at the trend over months rather than week to week.
- Note side effects and appetite changes, especially in the weeks after a dose increase.
- Bring your log to appointments so your prescriber can see what has changed since the last dose step.
When to Talk to Your Prescriber
- Severe or lasting stomach pain, or vomiting or diarrhea that stops you keeping fluids down: contact your prescriber or seek medical care promptly[1]
- Questions about whether to move to the next dose
- If your main goal is weight loss, to discuss whether a treatment approved for weight management fits you better
Frequently Asked Questions
How much weight do people lose in the first month on Ozempic?
The sources cited here do not report a first-month figure. The first 4 weeks are spent on the 0.25 mg starting dose, which the label uses to ease your body in and lower the risk of stomach side effects before moving to 0.5 mg.
How much weight can you lose on Ozempic?
In SUSTAIN FORTE, adults with type 2 diabetes lost an average of 5.6 kg (about 12 lb) on 1 mg and 6.4 kg (about 14 lb) on 2 mg over 40 weeks. Individual results vary widely. Weight loss is not among Ozempic's approved uses; it is prescribed for blood sugar control and to lower heart and kidney risks.
Is Ozempic approved for weight loss?
No. Weight loss is not among its approved uses. Ozempic is approved for adults with type 2 diabetes, to improve blood sugar control and to lower the risk of certain heart and kidney problems.
Why do Wegovy weight-loss numbers look so much bigger?
Wegovy is the semaglutide brand approved for weight management (as a weekly injection or a daily tablet), and the usual maintenance dose of the injection is 2.4 mg, the dose studied in the STEP trials. STEP 1 enrolled adults without diabetes, who lost an average of 14.9% of their body weight over 68 weeks. In STEP 2, the same 2.4 mg dose in adults with type 2 diabetes produced 9.6%. The Ozempic injection tops out at 2 mg, and the trials differ in length and design, so the numbers cannot be compared directly.
Sources and References
[1] Novo Nordisk. "OZEMPIC (semaglutide) injection: Full Prescribing Information." Section 1, Indications and Usage; Section 2, Dosage and Administration; Section 5, Warnings and Precautions. https://www.novo-pi.com/ozempic.pdf
[2] Frías JP, et al. "Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial." Lancet Diabetes Endocrinol. 2021;9(9):563-574. https://pubmed.ncbi.nlm.nih.gov/34293304/
[3] Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." N Engl J Med. 2021;384(11):989-1002 (STEP 1). https://pubmed.ncbi.nlm.nih.gov/33567185/
[4] Davies M, et al. "Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial." Lancet. 2021;397(10278):971-984. https://pubmed.ncbi.nlm.nih.gov/33667417/
[5] Novo Nordisk. "WEGOVY (semaglutide) injection: Full Prescribing Information." Section 2, Dosage and Administration. https://www.novo-pi.com/wegovy.pdf
[6] Novo Nordisk. "RYBELSUS and OZEMPIC (semaglutide) tablets: Full Prescribing Information." Section 2, Dosage and Administration. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Every person's experience with Ozempic is different. Always consult your healthcare provider about your situation, dosing and treatment plan, and never change your dose without their guidance.

